Chengdu BioArt Biotech

Chengdu CapitalBio Technology, often referred to as Chengdu Bio-Art Biotech, is a prominent Chinese biotechnology firm specializing in microfluidic chip technology and molecular diagnostics. As a core subsidiary of the CapitalBio Group, the company focuses on the development and large-scale manufacturing of lab-on-a-chip systems for clinical and research applications. Their extensive product portfolio includes diagnostic chips for the rapid detection of respiratory pathogens, genetic hearing loss screening, and drug-resistant tuberculosis. Headquartered in Chengdu's Tianfu Bio-Town, the company operates one of the world's largest production bases for microfluidic chips and provides integrated diagnostic solutions to thousands of hospitals and healthcare providers across China.